Home
About
Overview
Sharing Data
ORCID
Help
History (30)
Corrigendum: Adaptive and innate immune responses in multiple sclerosis with anti-CD20 therapy: gene expression and protein profiles.
A phase I clinical trial of RNF43 peptide-related immune cell therapy combined with low-dose cyclophosphamide in patients with advanced solid tumors.
Enhancement-constrained acceleration: A robust reconstruction framework in breast DCE-MRI.
Principal Investigator
Response to treatment in a prospective national infantile spasms cohort.
See All 30 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Response to treatment in a prospective national infantile spasms cohort.
Response to treatment in a prospective national infantile spasms cohort. Ann Neurol. 2016 Mar; 79(3):475-84.
View in:
PubMed
subject areas
Administration, Oral
Adrenal Cortex Hormones
Adrenocorticotropic Hormone
Anticonvulsants
Child, Preschool
Cohort Studies
Female
Humans
Infant
Male
Prevalence
Prospective Studies
Risk Factors
Spasms, Infantile
United States
Vigabatrin
authors with profiles
Douglas Nordli